According to the research report, the global short-read sequencing market size is expected to touch USD 36 Billion by 2032, from USD 6.3 Billion in 2022, growing with a significant CAGR of 19.04% from 2023 to 2032.
The short-read sequencing report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global short-read sequencing in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global short-read sequencing market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global short-read sequencing during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/2887
Report Scope of the Short-read Sequencing Market:
| Report Coverage | Details |
| Market Size in 2023 | USD 7.5 Billion |
| Market Size by 2032 | USD 36 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 19.4% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Technology, By Workflow, By Product, By Application, and By End User |
This study covers a detailed segmentation of the global short-read sequencing market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global short-read sequencing market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- BGI
- Agilent Technologies
- Thermo Fisher Scientific, Inc.
- ProPhase Labs, Inc. (Nebula Genomics)
- Illumina, Inc.
- Psomagen
- QIAGEN
- Azenta US, Inc. (GENEWIZ)
- PerkinElmer, Inc.
- Pacific Biosciences of California, Inc.
- Cytiva
- Fasteris SA
- Genewiz
- GenScript
Market Segmentation
By Technology
- Next-Generation Sequencing
- Sanger Sequencing
By Workflow
- Pre-Sequencing
- Sequencing
- Data Analysis
By Product
- Instruments
- Consumables
- Services
By Application
- Clinical Investigation
- Oncology
- Reproductive Health
- Consumer Genomics
- Agri genomics and Forensics
- HLA Typing/ Immune System Monitoring
By End User
- Academic Research
- Hospital and Clinics
- Clinical Research
- Pharmaceutical and Biotechnology Companies
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global short-read sequencing report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global short-read sequencing market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Short-read Sequencing Market
5.1. COVID-19 Landscape: Short-read Sequencing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Short-read Sequencing Market, By Technology
8.1. Short-read Sequencing Market, by Technology, 2023-2032
8.1.1. Next-Generation Sequencing
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Sanger Sequencing
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Short-read Sequencing Market, By Workflow
9.1. Short-read Sequencing Market, by Workflow, 2023-2032
9.1.1. Pre-Sequencing
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Sequencing
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Data Analysis
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Short-read Sequencing Market, By Product
10.1. Short-read Sequencing Market, by Product, 2023-2032
10.1.1. Instruments
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Consumables
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Services
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Short-read Sequencing Market, By Application
11.1. Short-read Sequencing Market, by Application, 2023-2032
11.1.1. Clinical Investigation
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Reproductive Health
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Consumer Genomics
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Agri genomics and Forensics
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. HLA Typing/ Immune System Monitoring
11.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Short-read Sequencing Market, By End User
12.1. Short-read Sequencing Market, by End User, 2023-2032
12.1.1. Academic Research
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Hospital and Clinics
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Clinical Research
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Pharmaceutical and Biotechnology Companies
12.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Short-read Sequencing Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Technology (2020-2032)
13.1.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.1.3. Market Revenue and Forecast, by Product (2020-2032)
13.1.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.5. Market Revenue and Forecast, by End User (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.5. Market Revenue and Forecast, by End User (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Technology (2020-2032)
13.1.7.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.1.7.3. Market Revenue and Forecast, by Product (2020-2032)
13.1.7.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.7.5. Market Revenue and Forecast, by End User (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.5. Market Revenue and Forecast, by End User (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.7. Market Revenue and Forecast, by Application (2020-2032)
13.2.8. Market Revenue and Forecast, by End User (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.10. Market Revenue and Forecast, by Application (2020-2032)
13.2.11. Market Revenue and Forecast, by End User (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.13. Market Revenue and Forecast, by End User (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.15. Market Revenue and Forecast, by End User (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.5. Market Revenue and Forecast, by End User (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.7. Market Revenue and Forecast, by End User (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.9. Market Revenue and Forecast, by End User (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.5. Market Revenue and Forecast, by End User (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.5. Market Revenue and Forecast, by End User (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.5. Market Revenue and Forecast, by End User (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.7. Market Revenue and Forecast, by End User (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.9. Market Revenue and Forecast, by End User (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.5. Market Revenue and Forecast, by End User (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.5. Market Revenue and Forecast, by End User (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Technology (2020-2032)
13.5.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.5.3. Market Revenue and Forecast, by Product (2020-2032)
13.5.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.5. Market Revenue and Forecast, by End User (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.7. Market Revenue and Forecast, by End User (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Technology (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Product (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.5. Market Revenue and Forecast, by End User (2020-2032)
Chapter 14. Company Profiles
14.1. BGI
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Thermo Fisher Scientific, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ProPhase Labs, Inc. (Nebula Genomics)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Illumina, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Psomagen
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. QIAGEN
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Azenta US, Inc. (GENEWIZ)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. PerkinElmer, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Pacific Biosciences of California, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments